Tobin, Andrew B. http://orcid.org/0000-0002-1807-3123
Article History
Accepted: 28 June 2024
First Online: 14 August 2024
Competing interests
: A.T. is fully employed by the University of Glasgow but is also co-founder and CEO of the spin-out company Keltic Pharma Therapeutics Ltd, which has an interest in targeting muscarinic receptors in neurological disease.